Tag: Dr Vijay Chandru
JNCASR, CrisprBits join hands to set up CRISPR Centre of Excellence...
The CoE-CIT is envisioned to bridge the bench to bed gap leading and have therapeutic impact by combining JNCASR’s strengths in fundamental biomedical sciences with CrisprBits’ expertise
CrisprBits raises USD 3 million to scale its CRISPR platforms for...
The new capital will be deployed to scale commercialization of the PathCrisp molecular diagnostics platform, augmenting manufacturing capacity for high-impact tests in human health
CrisprBits’ OmiCrisp tracks JN.1 variant in sewage samples in Bengaluru
The test is currently being used to monitor sewage samples in 14 localities in Bengaluru
Biotech startup CrisprBits raises 250,000 USD in pre-seed round from US-based...
The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial resistance genes associated with hospital-acquired infections
Strand Life Sciences receives CAP re-accreditation for its personalized genomics centre
Extension of College of American Pathologists accreditation following a recent inspection of Strand Centre for Genomics and Personalized Medicine Lab in Bangalore..............
“Biotech industry still requires significant research & innovation in varied areas”
Mentioned Dr Vijay Chandru, Chairman and Managing Director, Strand Life Sciences who believes that the markets will also see closer collaborations between biotech and pharmaceutical companies to offer more comprehensive treatment options.............
BioVoice eMag May 2017 Issue-12 Volume-1
BioVoice eMag May 2017 Issue-12 Volume-1:
The startup special ‘May 2017’ edition of BioVoice eMagazine includes the cover story, ‘THE STARTUP FACTOR’, that looks at...
Strand Life Sciences launches ground-breaking method for monitoring cancer
Strand LB helps monitor lung, breast, colorectal and other cancers for tumor presence, response, and recurrence.........
Strand Life Sciences creates global bioinformatics landmark with Strand Ramanujan
Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark.....





























































